Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Seliger

Showing results (81-90 of 85) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 85 results.
Human Genetics|June 1, 1996
Detection of a germline mutation and somatic homozygous loss of the von Hippel-Lindau tumor-suppressor gene in a family with a de novo mutation. A combined genetic study, including cytogenetics, PCR/SSCP, FISH, and CGHH J Decker, C Neuhaus, A Jauch, et al.
International Journal of Cancer|December 15, 1994
Cellular immune response to human renal-cell carcinomas: definition of a common antigen recognized by HLA-A2-restricted cytotoxic T-lymphocyte (CTL) clonesH Bernhard, J Karbach, T Wölfel, et al.
Tissue Antigens|July 31, 2007
Analysis of HLA class I-II haplotype frequency and segregation in a cohort of patients with advanced stage ovarian cancerZ Gamzatova, L Villabona, H van der Zanden, et al.
Clinical and Experimental Immunology|July 13, 2020
Comprehensive flow cytometric reference intervals of leukocyte subsets from six study centers across EuropeA Oras, B Quirant-Sanchez, D Popadic, et al.
Scandinavian Journal of Immunology|September 1, 1996
Recognition of human renal cell carcinoma and melanoma by HLA-A2-restricted cytotoxic T lymphocytes is mediated by shared peptide epitopes and up-regulated by interferon-gammaH Bernhard, M J Maeurer, E Jäger, et al.
Pageof 9

Showing results (81-90 of 85) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 85 results.
Human Genetics|June 1, 1996
Detection of a germline mutation and somatic homozygous loss of the von Hippel-Lindau tumor-suppressor gene in a family with a de novo mutation. A combined genetic study, including cytogenetics, PCR/SSCP, FISH, and CGHH J Decker, C Neuhaus, A Jauch, et al.
International Journal of Cancer|December 15, 1994
Cellular immune response to human renal-cell carcinomas: definition of a common antigen recognized by HLA-A2-restricted cytotoxic T-lymphocyte (CTL) clonesH Bernhard, J Karbach, T Wölfel, et al.
Tissue Antigens|July 31, 2007
Analysis of HLA class I-II haplotype frequency and segregation in a cohort of patients with advanced stage ovarian cancerZ Gamzatova, L Villabona, H van der Zanden, et al.
Clinical and Experimental Immunology|July 13, 2020
Comprehensive flow cytometric reference intervals of leukocyte subsets from six study centers across EuropeA Oras, B Quirant-Sanchez, D Popadic, et al.
Scandinavian Journal of Immunology|September 1, 1996
Recognition of human renal cell carcinoma and melanoma by HLA-A2-restricted cytotoxic T lymphocytes is mediated by shared peptide epitopes and up-regulated by interferon-gammaH Bernhard, M J Maeurer, E Jäger, et al.
Pageof 9